Search results for "Keeping tabs"
Spotlight on technology for pregnant diabetes patients
Studies of continuous glucose monitoring in pregnant patients with type 1 or 2 diabetes highlighted the effects of time in range on neonatal outcomes, while two others tested automated insulin delivery during pregnancy in type 1 diabetes patients.
https://diabetes.acponline.org/archives/2023/10/13/5.htm
13 Oct 2023
Spotlight on novel therapies for type 1 diabetes
Manufacturer trials reported the effects of weekly insulin and teplizumab in patients with type 1 diabetes, while recent reviews looked at preventing beta-cell loss with various therapeutics and using drugs approved for type 2 diabetes to combat chronic kidney disease in type 1.
https://diabetes.acponline.org/archives/2023/11/10/5.htm
10 Nov 2023
Spotlight on glycemia and dementia
One study found reduced rates of dementia in patients with type 2 diabetes who took metformin, while another showed that impaired fasting glucose posed a cognitive risk, and a review compared diabetes drug classes for their effects on dementia risk.
https://diabetes.acponline.org/archives/2023/12/08/5.htm
8 Dec 2023
Spotlight on the 2024 Standards of Care
The American Diabetes Association made its annual updates to the Standards of Care in Diabetes, addressing newer drug classes and growing evidence for bariatric surgery and heart failure screening, among many other changes.
https://diabetes.acponline.org/archives/2024/01/12/5.htm
12 Jan 2024
Spotlight on comparisons within diabetes drug classes
One review found tirzepatide to have more effect on glycemic outcomes than other glucagon-like peptide-1 receptor agonists, while another showed several sodium-glucose cotransporter-2 inhibitors to have similar effects on cardiovascular outcomes.
https://diabetes.acponline.org/archives/2024/02/09/5.htm
9 Feb 2024
Spotlight on NAFLD
Recent studies looked at the risks associated with nonalcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), the effects of diabetes drugs on the condition, and whether machine learning can help identify patients at risk.
https://diabetes.acponline.org/archives/2024/03/08/5.htm
8 Mar 2024
Spotlight on limitations of the HbA1c test
A recent position statement called for use of one-hour glucose tolerance testing for diabetes diagnosis, a review described limitations of point-of-care HbA1c testing, and a study identified differences in the relationship between fasting glucose and HbA1c level by race, age, and sex.
https://diabetes.acponline.org/archives/2024/04/12/5.htm
12 Apr 2024